http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2877550-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb67b9d458e3afbce334082a425e249a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
filingDate 2013-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d316b3e6b429467ba1247e53c7c656b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8668ba34ca5fe4461144eaa46f6225dd
publicationDate 2021-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2877550-T3
titleOfInvention Ophthalmic composition
abstract Ophthalmic composition consisting of: an aqueous solution of hyaluronic acid (HA) or a pharmaceutically acceptable salt thereof; polyvinylpyrrolidone (PVP); an amount of an inorganic salt sufficient to bring the composition to a predetermined osmolarity; strong acid or strong base as necessary to bring the composition to a predetermined pH; and optionally, a buffer; characterized in that said ophthalmic composition is suitable for topical administration; and said ophthalmic composition is characterized by a concentration of HA or a pharmaceutically acceptable salt thereof of about 0.1% w/v and a concentration of PVP of about 5% w/v, where the term "about" refers to amounts within of ±25% of the amount expressed.
priorityDate 2012-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453616683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71656137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454013444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21863217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 39.